XML 32 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Operating Activities      
Net income $ 10,866 $ 12,080 $ 10,301
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Client incentives 6,664 6,173 5,491
Share-based compensation 416 407 327
Depreciation and amortization of property, equipment, technology and intangible assets 767 656 613
Deferred income taxes 307 214 (1,277)
VE territory covered losses incurred (37) (172) (11)
Other (145) (271) (64)
Change in operating assets and liabilities:      
Settlement receivable 1,858 (1,533) (223)
Accounts receivable (43) (333) (70)
Client incentives (8,081) (6,430) (4,682)
Other assets (402) (310) 59
Accounts payable 21 (24) 3
Settlement payable (2,384) 1,931 262
Accrued and other liabilities 923 627 1,760
Accrued litigation (290) (231) 452
Net cash provided by (used in) operating activities 10,440 12,784 12,941
Investing Activities      
Purchases of property, equipment and technology (736) (756) (718)
Investment securities:      
Purchases (2,075) (2,653) (5,772)
Proceeds from maturities and sales 4,510 3,996 3,636
Acquisitions, net of cash and restricted cash acquired (77) (699) (196)
Purchases of / contributions to other investments (267) (501) (50)
Other investing activities 72 22 16
Net cash provided by (used in) investing activities 1,427 (591) (3,084)
Financing Activities      
Repurchase of class A common stock (8,114) (8,607) (7,192)
Proceeds from issuance of senior notes 7,212 0 0
Repayments of debt 0 0 (1,750)
Dividends paid (2,664) (2,269) (1,918)
Payment of deferred purchase consideration related to the Visa Europe acquisition 0 (1,236) 0
Cash proceeds from issuance of common stock under employee equity plans 190 162 164
Restricted stock and performance-based shares settled in cash for taxes (160) (111) (94)
Payments to settle derivative instruments (333) 0 0
Other financing activities (99) 0 0
Net cash provided by (used in) financing activities (3,968) (12,061) (10,790)
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents 440 (277) (101)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents 8,339 (145) (1,034)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year 10,832 10,977 12,011
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of year 19,171 10,832 10,977
Supplemental Disclosure      
Cash paid for income taxes, net 2,671 2,648 2,285
Interest payments on debt 537 537 545
Charitable contribution of investment securities to Visa Foundation 0 0 195
Accruals related to purchases of property, equipment and technology $ 38 $ 95 $ 77